⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL288792 | 1.00 | — | — | |
| SCHEMBL29479228 | 1.00 | — | — | |
| SCHEMBL34705 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2462827 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL29401163 | 0.97 | GSR (0.65) | — | |
| Hydrochloric Acid SCHEMBL318746 | 0.97 | GSR (0.65) | — | |
| Bromide SCHEMBL7013646 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL318747 | 0.97 | GSR (0.65) | — | |
| Bromide SCHEMBL29401581 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL2398999 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16683 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070294-A | Stable vitreous material based on histidine, arginine and glutamic acid amino acids | 阵序补丁有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122036624-A | Preparation method of high-purity exendin | 辽宁大学 | 2026-05-15 | — | — | CN | claimed |
| WO-2026100273-A1 | METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE | ＮＴＴ株式会社 | 2026-05-15 | — | — | WO | claimed |
| EP-3914605-B2 | PEPTIDE PRECIPITATION METHOD | DSM IP ASSETS BV (NL) | 2026-04-29 | — | — | EP | claimed |
| EP-4729529-A1 | PREPARATION OF PEPTIDE INHIBITOR OF INTERLEUKIN-23 RECEPTOR AND USE THEREOF | Xizang Haisco Pharmaceutical Co., Ltd. (CN) | 2026-04-22 | — | — | EP | claimed |
| US-20260103499-A1 | BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS | HAN JIE (US) | 2026-04-16 | — | — | US | claimed |
| EP-4725957-A1 | GROUP OF CYCLIC ALKALINE LIPOPEPTIDE COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) | 2026-04-15 | — | — | EP | claimed |
| US-20260071007-A1 | METHOD FOR OPTIMIZING VIRUS MEMBRANE FUSION INHIBITOR, AND BROAD-SPECTRUM ANTI-CORONAVIRUS LIPOPEPTIDE AND USE THEREOF | YOUCARE PHARMACEUTICAL GROUP CO., LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| US-20260071989-A1 | SINGLE-STRANDED DNA MOLECULAR RECOGNITION ELEMENTS AGAINST CYANOTOXIN L-BMAA | UNIV PUERTO RICO (US) | 2026-03-12 | — | — | US | claimed |
| EP-4696700-A1 | LONG-ACTING K-OPIOID RECEPTOR AGONIST | Chengdu Aoda Biotechnology Co., Ltd (CN) | 2026-02-18 | — | — | EP | claimed |
| EP-0070649-A2 | ML-236B Derivatives, a process for their preparation and pharmaceutical compositions containing them | SANKYO COMPANY LIMITED (JP) | 1983-01-26 | — | — | EP | claimed |
| EP-0065843-A1 | New M-4 and iso M-4 derivatives, their preparation and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1982-12-01 | — | — | EP | claimed |
| EP-0065835-A1 | M-4 and iso M-4 derivatives, their preparation and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1982-12-01 | — | — | EP | claimed |
| US-4290972-A | Process for the production of 4-aminobutyric acid or its derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 1981-09-22 | — | — | US | claimed |
| EP-0009498-A4 | EFFECTING CELLULAR UPTAKE OF MOLECULES. | UNIV BOSTON (US) | 1980-10-16 | — | — | EP | claimed |
| EP-0009498-A1 | EFFECTING CELLULAR UPTAKE OF MOLECULES. | UNIV BOSTON (US) | 1980-04-16 | — | — | EP | claimed |
| WO-1979000515-A1 | METHOD OF EFFECTING CELLULAR UPTAKE OF MOLECULES | UNIV BOSTON (US) | 1979-08-09 | — | — | WO | claimed |
| US-4091092-A | ANTIBIOTIC MIXTURE PRODUCED BY BACILLUS CIRCULANS | E. R. SQUIBB & SONS, INC. (US) | 1978-05-23 | — | — | US | claimed |
| US-3969501-A | Antibiotic 342-14-I and production thereof | SHIONOGI & CO., LTD. (JA) | 1976-07-13 | — | — | US | claimed |
| US-3941762-A | BACTERICIDE, FUNGICIDE | E. R. SQUIBB & SONS, INC. (US) | 1976-03-02 | — | — | US | claimed |